Cysteine engineered antibodies and conjugates
Abstract
Antibodies are engineered by replacing one or more amino acids of a parent antibody with non cross-linked, highly reactive cysteine amino acids. Antibody fragments may also be engineered with one or more cysteine amino acids to form cysteine engineered antibody fragments (ThioFab). Methods of design, preparation, screening, and selection of the cysteine engineered antibodies are provided. Cysteine engineered antibodies (Ab), optionally with an albumin-binding peptide (ABP) sequence, are conjugated with one or more drug moieties (D) through a linker (L) to form cysteine engineered antibody-drug conjugates having Formula I: Ab-(L-D) p I where p is 1 to 4. Diagnostic and therapeutic uses for cysteine engineered antibody drug compounds and compositions are disclosed.
Claims
exact text as granted — not AI-modified1 . A cysteine engineered antibody comprising one or more variable region heavy chain sequences with a free cysteine amino acid selected from SEQ ID NOS: 9-16:
WVRQCPGKGL
SEQ ID NO: 9
NSLRCEDTAV
SEQ ID NO: 10
LVTVCSASTKGPS
SEQ ID NO: 11
LVTVSCASTKGPS
SEQ ID NO: 12
LVTVSSCSTKGPS
SEQ ID NO: 13
LVTVSSACTKGPS
SEQ ID NO: 14
HTFPCVLQSSGLYS
SEQ ID NO: 15
HTFPAVLQCSGLYS
SEQ ID NO: 16
or comprising one or more variable region light chain sequences with a free cysteine amino acid selected from SEQ ID NOS: 17-27:
SLSASCGDRVT
SEQ ID NO: 17
QKPGKCPKLLI
SEQ ID NO: 18
EIKRTCAAPSV
SEQ ID NO: 19
TCAAPCVFIFPP
SEQ ID NO: 20
FIFPPCDEQLK
SEQ ID NO: 21
DEQLKCGTASV
SEQ ID NO: 22
FYPRECKVQWK
SEQ ID NO: 23
WKVDNCLQSGN
SEQ ID NO: 24
ALQSGCSQESV
SEQ ID NO: 25
VTEQDCKDSTY
SEQ ID NO: 26
GLSSPCTKSFN
SEQ ID NO: 27
wherein the cysteine engineered antibody binds to HER2.
2 . A cysteine engineered antibody comprising one or more Fc constant region heavy chain sequences with a free cysteine amino acid selected from SEQ ID NOS: 31, 33, 36, 37 and 38:
HEDPEVKFNWYVDGCEVHNAKTKPR
SEQ ID NO: 31
HEDPEVKFNWYVDGVEVHNCKTKPR
SEQ ID NO: 33
IEKTISKCKGQPR
SEQ ID NO: 36
KGFYPCDIAVE
SEQ ID NO: 37
PPVLDCDGSFF
SEQ ID NO: 38
wherein the cysteine engineered antibody binds to EphB2R.
3 . A cysteine engineered antibody comprising one or more variable region heavy chain sequences with a free cysteine amino acid selected from SEQ ID NOS: 40-44:
NWIRQCPGNK
SEQ ID NO: 40
LNSCTTEDTAT
SEQ ID NO: 41
GQGTLVTVSACSTKGPSVFPL
SEQ ID NO: 42
HTFPCVLQSSGLYS
SEQ ID NO: 43
HTFPACLQSSGLYS
SEQ ID NO: 44
or comprising one or more variable region light chain sequences with a free cysteine amino acid selected from SEQ ID NOS: 45-49:
FLSVSCGGRVT
SEQ ID NO: 45
QKPGNCPRLLI
SEQ ID NO: 46
EIKRTCAAPSV
SEQ ID NO: 47
FYPRECKVQWK
SEQ ID NO: 48
VTEQDCKDSTY
SEQ ID NO: 49
wherein the cysteine engineered antibody binds to MUC16.
4 . The cysteine engineered antibody of any one of claims 1 - 3 wherein the free cysteine amino acid is conjugated to a drug moiety selected from a maytansinoid, an auristatin, a dolastatin, or a calicheamicin.Join the waitlist — get patent alerts
Track US2011137017A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.